Loading…
LifeMD, Inc. is projected to rise to $6.38 by 2027, a +40% move from its current price of $4.57. LFMD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $4.37 | $4.57 | $4.78 | -0.06% |
| May 30 | $4.28 | $4.56 | $4.86 | -0.12% |
| May 31 | $4.22 | $4.56 | $4.93 | -0.18% |
| Jun 1 | $4.17 | $4.56 | $4.99 | -0.24% |
| Jun 2 | $4.12 | $4.56 | $5.04 | -0.30% |
| Jun 3 | $4.08 | $4.55 | $5.08 | -0.35% |
| Jun 4 | $4.04 | $4.55 | $5.12 | -0.41% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.04 | $4.55 | $5.12 | -0.41% |
| Week 2 | $3.83 | $4.53 | $5.36 | -0.82% |
| Week 3 | $3.67 | $4.51 | $5.54 | -1.23% |
| Week 4 | $3.55 | $4.49 | $5.70 | -1.64% |
| Week 5 | $3.43 | $4.48 | $5.84 | -2.05% |
| Week 6 | $3.33 | $4.46 | $5.96 | -2.45% |
| Week 7 | $3.24 | $4.44 | $6.08 | -2.85% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
LifeMD, Inc. operates as a direct-to-patient telehealth company, providing access to virtual medical care and pharmacy services in the United States. Its telehealth platforms include Rex MD, a men’s telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men’s health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety.
ShapiroMD provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices.
The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
LifeMD, Inc. trades under the symbol LFMD and currently quotes $4.57 per share. It has a market capitalization of $221.02M and ranks 3736 by overall market size.
The stock trades near its 50-day moving average of $4.21 and near its 200-day moving average of $4.58, placing the price near key averages.
The 30-day range spans from $3.40 to $6.14, signaling room for near-term movement.
Forecasts point to a bullish longer-term trajectory, with the 2026 average price at $4.57 and rising to higher levels in later years, including a 2027 average of $6.38, 2028 average of $7.91, 2029 average of $9.03, a 2030 average of $8.84, and a 2040 average of $18.88, culminating in a 2050 average of $47.10 and a max of $108.03; the projected max in 2030 is $14.58 and the long-run ROI to 2050 is 930.6. These figures indicate potential upside but remain subject to market conditions.
A major floor 42.2% below — a decisive break under it would weaken the trend.
The nearest floor, 16.2% below — buyers have tended to step in here.
The nearest ceiling, 15.3% above — a clean break opens room to run.
A major ceiling 31.2% above — clearing it would confirm fresh momentum.
Key LFMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LFMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.27 | Buy | $4.34 | Buy |
| MA 10 | $4.32 | Buy | $4.36 | Buy |
| MA 20 | $4.54 | Buy | $4.39 | Buy |
| MA 50 | $4.21 | Buy | $4.21 | Buy |
| MA 100 | $3.78 | Buy | $4.21 | Buy |
| MA 200 | $4.58 | Sell | $4.79 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.59 | Neutral |
| Stoch RSI (14) | 85.73 | Sell |
| CCI (20) | 8.07 | Neutral |
| Williams %R (14) | -29.58 | Info |
| MACD (12,26,9) | -0.05 | Sell |
| ROC (12) | -4.39 | Sell |
| Bollinger %B (20,2) | 0.52 | Neutral |
| Stochastic %K (14) | 70.42 | Neutral |
| TRIX (15) | 0.21 | Buy |
| Awesome (5,34) | -0.14 | Sell |
| Ultimate (7,14,28) | 55.13 | Neutral |
| Momentum (10) | 0.29 | Buy |
| Aroon Osc (25) | -44.00 | Sell |
| Hull MA (9) | 4.27 | Buy |
| ADX (14) | 12.75 | Neutral |
| ATR (14) | 0.18 | Info |
The 30-day technical picture is bullish at the moment with RSI14 at 50 and the stock trading around key moving averages. The SMA50 stands at $4.21 and the SMA200 at $4.58, placing the price near the longer-term trend line.
Immediate support sits at $3.83 and resistance at $5.27, giving a near-term trading corridor. The 30-day price range is $3.40 to $6.14, highlighting a solid near-term basis with potential for movement within that band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.64 | $4.57 | $7.07 | 0% | Neutral | |
| $4.75 | $6.38 | $9.25 | +40% | Bullish | |
| $5.60 | $7.91 | $12.08 | +73% | Bullish | |
| $6.14 | $9.03 | $14.39 | +98% | Bullish | |
| $5.79 | $8.84 | $14.58 | +93% | Bullish | |
| $6.08 | $9.60 | $16.32 | +110% | Bullish | |
| $5.89 | $9.60 | $16.77 | +110% | Bullish | |
| $5.99 | $10.08 | $18.05 | +121% | Bullish | |
| $8.17 | $14.16 | $25.91 | +210% | Bullish | |
| $9.24 | $16.49 | $30.81 | +261% | Bullish | |
| $9.21 | $18.88 | $38.39 | +313% | Bullish | |
| $21.19 | $47.10 | $108.03 | +931% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.64 | $4.57 | $5.43 | +0.00% |
| June 2026 | $3.77 | $4.49 | $5.52 | -1.79% |
| July 2026 | $3.58 | $4.33 | $5.44 | -3.53% |
| August 2026 | $3.74 | $4.57 | $5.84 | +5.61% |
| September 2026 | $3.86 | $4.76 | $6.15 | +3.98% |
| October 2026 | $3.74 | $4.65 | $6.10 | -2.12% |
| November 2026 | $3.85 | $4.83 | $6.39 | +3.72% |
| December 2026 | $4.20 | $5.29 | $7.07 | +9.63% |
Click any year to see its month-by-month LFMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect LFMD to range from $2.64 to $7.07 through 2026. The $4.57 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The LFMD price prediction for 2027 points to an average of $6.38 (low $4.75, high $9.25) — a potential gain of +40% on today's $4.57. Buyers look set to stay in control over this stretch.
In 2028, LFMD is projected to trade between $5.60 and $12.08, averaging $7.91 — a potential gain of +73% from today's $4.57. That is up +24% on the projected 2027 average. Momentum favours further upside here.
LifeMD, Inc.'s 2029 outlook centres on $9.03, within a $6.14 to $14.39 range. That is up +14% on the projected 2028 average. That marks a +98% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, LFMD could reach as high as $14.58, with a base case around $8.84 and support toward $5.79 — roughly +93% from $4.57. Momentum favours further upside here.
Expect LFMD to range from $6.08 to $16.32 through 2031. The $9.60 average target implies a +110% move from current prices. That is up +9% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The LFMD price prediction for 2032 points to an average of $9.60 (low $5.89, high $16.77) — a potential gain of +110% on today's $4.57. Momentum favours further upside here.
In 2033, LFMD is projected to trade between $5.99 and $18.05, averaging $10.08 — a potential gain of +121% from today's $4.57. That is up +5% on the projected 2032 average. Buyers look set to stay in control over this stretch.
LifeMD, Inc.'s 2034 outlook centres on $14.16, within a $8.17 to $25.91 range. That is up +40% on the projected 2033 average. That marks a +210% change versus current levels. Momentum favours further upside here.
By 2035, LFMD could reach as high as $30.81, with a base case around $16.49 and support toward $9.24 — roughly +261% from $4.57. Buyers look set to stay in control over this stretch.
Expect LFMD to range from $9.21 to $38.39 through 2040. The $18.88 average target implies a +313% move from current prices. That is up +14% on the projected 2035 average. Momentum favours further upside here.
The LFMD price prediction for 2050 points to an average of $47.10 (low $21.19, high $108.03) — a potential gain of +931% on today's $4.57. Buyers look set to stay in control over this stretch.
Investing $1,000 in LFMD today (≈ 218.818381 LFMD) could be worth
$10,306.33
+$9,306.33 (+931%) by 2050 · US Dollar
Based on the average projected LFMD price of $47.1 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LFMDwould be worth at today's price.
$1,000 invested in LFMD on May 27, 2025 (≈ 86.655113 LFMD) would be worth
$396.01
-$603.99 (-60.4%) today · 0.40× · US Dollar
Based on a LFMD entry price of $11.54 vs. today's $4.57.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.26 | $1,072.77 | +7.3% |
| 1 month ago | $4.57 | $1,000 | -0.0% |
| 3 months ago | $2.78 | $1,643.88 | +64.4% |
| 6 months ago | $3.83 | $1,193.21 | +19.3% |
| 1 year ago | $11.54 | $396.01 | -60.4% |
| All time (5.0y) ago | $12.69 | $360.13 | -64.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LFMD forecast.
Our base-case forecast reaches $9.10 around 2031.
Implied market cap at $9.10: $440.1M
The multi-year forecast shows a generally bullish trajectory after a neutral near-term start. By 2027 the average price is projected at $6.38 with a 39.7 ROI and bullish sentiment, followed by 2028 at $7.91 (73) and 2029 at $9.03 (97.6). The 2030 forecast remains strong, with an average price of $8.84 and a 93.3 ROI, indicating continued upside despite a slight dip from 2029.
Looking further ahead, 2031–2033 show continued gains with 2031 at $9.60 (110), 2032 at $9.60 (110.1), and 2033 at $10.08 (120.6). The long-range outlook accelerates in 2034–2035, with 2034 averaging $14.16 (209.8) and 2035 at $16.49 (260.9). By 2040 the average price is projected to $18.88 with a 313.1 ROI, and by 2050 the average expands to $47.10 with a 930.6 ROI, with a max reaching $108.03.
While these figures imply significant upside, they are estimates and subject to market dynamics and other risks.
Tap a question to reveal the answer.
For 2030, the forecast shows an avg price of $8.84 with a max of $14.58 and a ROI of 93.3; sentiment is BULLISH.
Forecasts show sentiment turning BULLISH from 2027 onward with rising averages (e.g., 2027 avg $6.38, 2028 avg $7.91, 2029 avg $9.03) and a long-run 2050 avg of $47.10, but 2026 is NEUTRAL and all forecasts are not guaranteed.
The 2050 max is $108.03, which includes values above $100 across the forecast horizon.
The 2050 average is $47.10 and the 2050 max is $108.03, indicating the possibility of reaching around the $50 level in the long run.
Current price is $4.57 with a 30-day range of $3.40 to $6.14; 50-day SMA is $4.21 and 200-day SMA is $4.58, with support at $3.83 and resistance at $5.27.
LifeMD, Inc. Community Discussion
0Share your LifeMD, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.